IKPM Stock Overview
Engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
PT Ikapharmindo Putramas Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp266.00 |
| 52 Week High | Rp332.00 |
| 52 Week Low | Rp172.00 |
| Beta | 0 |
| 11 Month Change | -6.34% |
| 3 Month Change | -5.00% |
| 1 Year Change | 52.87% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 46.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| IKPM | ID Personal Products | ID Market | |
|---|---|---|---|
| 7D | -2.9% | -2.4% | -2.2% |
| 1Y | 52.9% | 9.0% | 9.3% |
Return vs Industry: IKPM exceeded the ID Personal Products industry which returned 9% over the past year.
Return vs Market: IKPM exceeded the ID Market which returned 9.3% over the past year.
Price Volatility
| IKPM volatility | |
|---|---|
| IKPM Average Weekly Movement | 2.0% |
| Personal Products Industry Average Movement | 3.4% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: IKPM has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: IKPM's weekly volatility has decreased from 8% to 2% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 1,030 | . Kartono | www.ikapharmindo.com |
PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in the areas of neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics, generics, and nutraceuticals; and over-the-counter drugs.
PT Ikapharmindo Putramas Tbk Fundamentals Summary
| IKPM fundamental statistics | |
|---|---|
| Market cap | Rp448.12b |
| Earnings (TTM) | Rp8.81b |
| Revenue (TTM) | Rp424.36b |
50.8x
P/E Ratio1.1x
P/S RatioIs IKPM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IKPM income statement (TTM) | |
|---|---|
| Revenue | Rp424.36b |
| Cost of Revenue | Rp238.62b |
| Gross Profit | Rp185.74b |
| Other Expenses | Rp176.92b |
| Earnings | Rp8.81b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.23 |
| Gross Margin | 43.77% |
| Net Profit Margin | 2.08% |
| Debt/Equity Ratio | 61.4% |
How did IKPM perform over the long term?
See historical performance and comparison